Cargando…
Recent Advances in Lentiviral Vaccines for HIV-1 Infection
The development of an effective HIV vaccine to prevent and/or cure HIV remains a global health priority. Given their central role in the initiation of adaptive immune responses, dendritic cell (DC)-based vaccines are being increasingly explored as immunotherapeutic strategies to enhance HIV-specific...
Autores principales: | Norton, Thomas D., Miller, Elizabeth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914507/ https://www.ncbi.nlm.nih.gov/pubmed/27446074 http://dx.doi.org/10.3389/fimmu.2016.00243 |
Ejemplares similares
-
Corrigendum: Recent Advances in Lentiviral Vaccines for HIV-1 Infection
por: Norton, Thomas D., et al.
Publicado: (2016) -
Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens
por: Gallinaro, Alessandra, et al.
Publicado: (2018) -
The Hitchhiker Guide to CD4(+) T-Cell Depletion in Lentiviral Infection. A Critical Review of the Dynamics of the CD4(+) T Cells in SIV and HIV Infection
por: Le Hingrat, Quentin, et al.
Publicado: (2021) -
Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses
por: Nemirov, Kirill, et al.
Publicado: (2023) -
Reconstitution of the Ataxia-Telangiectasia Cellular Phenotype With Lentiviral Vectors
por: Carranza, Diana, et al.
Publicado: (2018)